跳至主要内容
临床试验/NCT03846895
NCT03846895已完成不适用

The Role of the Micro-ablative Fractional CO2 Laser in Postmenopausal Women With Overactive Bladder Syndrome.

National and Kapodistrian University of Athens2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年5月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
Overactive Bladder questionaire (OAB-q)

研究概览

简要总结

This study evaluates the clinical efficacy and symptom relief of vaginal fractional CO2 laser treatment in post-menopausal women with Overactive Bladder syndrome(OAB). Post-menopausal women with OAB syndrome who receive β3 adrenergic receptors (mirabegron 50mg) treatment, will be randomized in two groups. Half participants will receive active CO2 laser therapy, while the other half will receive placebo CO2 laser therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Postmenopausal women (≥ 12 months of amenorrhea or FSH ≥ 40 after hysterectomy with bilateral oophorectomy) who receive β3 adrenergic receptors (mirabegron 50 mg) treatment for OAB
  • Overactive bladder syndrome (OAB)
  • ≥ 3 months symptoms of urgency, with or without urinary incontinence, and ≥ 8 micturitions / 24h
  • At least 3 episodes of urgent urination (3rd-4th grade) as recorded in the patient perception intensity of urgency scale (PPiUS) during a 3 day urination calendar , with or without urinary incontinence.

排除标准

  • Participants with:
  • Pelvic Organ Prolapse (POP) > stage II of the pelvic organ prolapse quantitation system (POP-Q)
  • Post void residual volume > 200 ml (measured by ultrasound)
  • Use of moisturizers or lubricants the last month
  • Use of vaginal estrogen in the last 6 months
  • Use of drugs for urinary incontinence
  • Use of psychotropic drugs
  • Symptomatic urinary tract infection
  • Active genital infection
  • Kidney or liver disease
  • Abnormal cardiac conduction, rate or rythm disorders
  • Diabetic neuropathy
  • Myasthenia gravis
  • History of malignant disease
  • Previous radio-chemo therapy

结局指标

主要结局

Overactive Bladder questionaire (OAB-q)

时间窗: 24 months

It consists of an 8 item symptom bother scale section and a 25 item health related quality of life scale section (HRQL). Scores of each domain of the 2 sections range from 0 to 100. Higher scores indicate higher impact of overactive bladder symptoms.

3 days voiding diary

时间窗: 24 months

Assesses bladder function (frequency of micturition, urgency and urinary incontinence)

次要结局

  • Patients Global Impression of Improvement (PGI-I)(24 months)
  • Pelvic Floor Impact Questionnaire-short form 7 (PFIQ-7)(24 months)
  • King's Health Questionnaire (KHQ)(24 months)
  • Urogenital Distress Inventory questionaire (UDI-6)(24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Themos Grigoriadis

Assistant Professor

National and Kapodistrian University of Athens

研究点 (2)

Loading locations...

相似试验